Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.

[1]  R. M. Lee,et al.  The effects of quinapril and atorvastatin on artery structure and function in adult spontaneously hypertensive rats. , 2005, European journal of pharmacology.

[2]  P. Gosse.  Left ventricular hypertrophy as a predictor of cardiovascular risk , 2005, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[3]  N. Chang,et al.  Effect of simvastatin on left ventricular mass in hypercholesterolemic rabbits. , 2005, American journal of physiology. Heart and circulatory physiology.

[4]  J. Davignon.  Beneficial Cardiovascular Pleiotropic Effects of Statins , 2004, Circulation.

[5]  T. Yano,et al.  Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. , 2004, Biochemical pharmacology.

[6]  M. Kamphuis,et al.  Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels. , 2003, Blood.

[7]  Kazuo Ichihara,et al.  All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells. , 2003, Atherosclerosis.

[8]  G. Berry,et al.  Simvastatin Rescues Rats From Fatal Pulmonary Hypertension by Inducing Apoptosis of Neointimal Smooth Muscle Cells , 2003, Circulation.

[9]  M. Hristov,et al.  HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. , 2003, Atherosclerosis.

[10]  J. Vamvakopoulos,et al.  HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection , 2003, BMC cardiovascular disorders.

[11]  A. Ortiz,et al.  Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells. , 2003, Kidney international.

[12]  J. G. Harrison,et al.  Regulation of cardiac myocyte cell death. , 2003, Pharmacology & therapeutics.

[13]  G. Maurer,et al.  Plasminogen Activator Inhibitor 1 Expression is Regulated by the Inflammatory Mediators Interleukin-1α, Tumor Necrosis Factor-α, Transforming Growth Factor-β and Oncostatin M in Human Cardiac Myocytes ☆ , 2002 .

[14]  U. Ikeda,et al.  Fluvastatin Induces Apoptosis in Rat Neonatal Cardiac Myocytes: A Possible Mechanism of Statin-Attenuated Cardiac Hypertrophy , 2002, Journal of cardiovascular pharmacology.

[15]  Georg Ertl,et al.  Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study. , 2002, Journal of the American College of Cardiology.

[16]  M. Igarashi,et al.  Mechanisms of Inhibitory Effects of Cerivastatin on Rat Vascular Smooth Muscle Cell Growth , 2002, Journal of cardiovascular pharmacology.

[17]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[18]  Xianwu Li,et al.  Inhibition of Protein Geranylgeranylation and RhoA/RhoA Kinase Pathway Induces Apoptosis in Human Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[19]  Á. Pascual,et al.  3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. , 2002, Atherosclerosis.

[20]  Hiroyuki Tsutsui,et al.  Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction , 2002, Circulation.

[21]  U. Ikeda,et al.  Fluvastatin Enhances Apoptosis in Cytokine-Stimulated Vascular Smooth Muscle Cells , 2002, Journal of cardiovascular pharmacology.

[22]  Afshin Samali,et al.  Losing heart: the role of apoptosis in heart disease—a novel therapeutic target? , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  G. Maurer,et al.  HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins , 2002, British journal of pharmacology.

[24]  B. Antonsson.  Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion , 2001, Cell and Tissue Research.

[25]  P. Galuppo,et al.  Improvement of Left Ventricular Remodeling and Function by Hydroxymethylglutaryl Coenzyme A Reductase Inhibition With Cerivastatin in Rats With Heart Failure After Myocardial Infarction , 2001, Circulation.

[26]  M. Quiñones,et al.  Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy , 2001, Circulation.

[27]  W. W. Zhang,et al.  Simvastatin inhibits noradrenaline‐induced hypertrophy of cultured neonatal rat cardiomyocytes , 2001, British journal of pharmacology.

[28]  A. Ruello,et al.  Cardiovascular remodeling, apoptosis, and drugs. , 2000, American journal of hypertension.

[29]  T. N. James,et al.  Apoptosis in cardiac disease. , 1999, The American journal of medicine.

[30]  Gui-ping Zhang,et al.  SIMVASTATIN INHIBITS CARDIAC HYPERTROPHY AND ANGIOTENSIN‐CONVERTING ENZYME ACTIVITY IN RATS WITH AORTIC STENOSIS , 1999, Clinical and experimental pharmacology & physiology.

[31]  P. Hamet,et al.  Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity. , 1999, Hypertension.

[32]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[33]  J. Kawabe,et al.  Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells. , 1999, European journal of pharmacology.

[34]  A. Allegra,et al.  Pro-apoptotic effect of fluvastatin on human smooth muscle cells. , 1999, European journal of pharmacology.

[35]  G. Takemura,et al.  Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. , 1998, Circulation research.

[36]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[37]  L. Kirshenbaum,et al.  The bcl-2 gene product prevents programmed cell death of ventricular myocytes. , 1997, Circulation.

[38]  E. Donetti,et al.  Proapoptotic effect of atorvastatin on stimulated rabbit smooth muscle cells. , 1997, Pharmacological research.

[39]  Y. Horsmans,et al.  Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors , 1996, Clinical pharmacokinetics.

[40]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[41]  R. Gascoyne,et al.  Short Communication Immunohistochemical Analysis of Mci-1 Protein in Human Tissues Differential Regulation of Mcl- 1 and Bcl-2 Protein Production Suggests a Unique Role for Mcl- 1 in Control of Programmed Cell Death In Vivo , 2007 .

[42]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[43]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[44]  R. Craig,et al.  MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. Melnykovych,et al.  Defective utilization of cholesterol esters from low-density lipoprotein in a human acute lymphoblastic leukemia T cell line. , 1988, Biochimica et biophysica acta.

[46]  L. Kirshenbaum,et al.  Apoptosis of ventricular myocytes: a means to an end. , 2005, Journal of molecular and cellular cardiology.

[47]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[48]  R. Zimlichman,,et al.  Simvastatin Induces Apoptosis of Cultured Rat Cardiomyocytes , 2001, Journal of basic and clinical physiology and pharmacology.

[49]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.